 |
|
Researchers identify 5 genetic variations associated with risk of venous thrombosis in women
February 07, 2007Researchers have identified new genetic variations that may be associated with the risk of developing nonfatal venous thrombosis in postmenopausal women, according to a study in the February 7 issue of JAMA.
Deep vein thrombosis (blood clots in the thigh or leg) and pulmonary embolism (blood clots in the arteries leading to the lungs) cause significant illness and death in adult women, according to the background information in the article. The authors note that despite improved preventive treatments in high-risk patients, the incidence of venous thrombosis (VT) has not decreased.
In this study, Nicholas L. Smith, Ph.D., M.P.H., from the University of Washington, Seattle, and colleagues examined the association of common genetic variation in 24 clotting-related candidate genes with the risk of first-time VT in postmenopausal women. Study participants were 349 perimenopausal and postmenopausal women 30 to 89 years of age who sustained a first VT event between January 1995 and December 2002. The control group of 1,680 women included perimenopausal and postmenopausal women of the same age range who had no prior history of deep vein thrombosis or pulmonary embolism. Through blood samples taken from the study participants, the researchers analyzed genetic markers called haplotypes and changes in the DNA sequence called single nucelotide polymorphisms (SNP).
"Only the tissue factor pathway inhibitor gene demonstrated global association with risk. Five significant SNP associations were identified across three of the candidate genes (factors V, XI and protein C) in SNP analyses," the researchers report. Two of those associations had been previously reported. The researchers note that another 22 variants across 15 genes were also identified and classify them as "interesting associations."
"After accounting for multiple testing, five SNPs associated with VT risk were identified, three of which have not been previously reported. Replication of these novel associations in other populations is necessary to corroborate these findings and identify which genetic factors may influence VT risk in postmenopausal women," the authors conclude.
JAMA and Archives Journals
"Only the tissue factor pathway inhibitor gene demonstrated global association with risk. Five significant SNP associations were identified across three of the candidate genes (factors V, XI and protein C) in SNP analyses," the researchers report. Two of those associations had been previously reported. The researchers note that another 22 variants across 15 genes were also identified and classify them as "interesting associations."
"After accounting for multiple testing, five SNPs associated with VT risk were identified, three of which have not been previously reported. Replication of these novel associations in other populations is necessary to corroborate these findings and identify which genetic factors may influence VT risk in postmenopausal women," the authors conclude.
JAMA and Archives Journals
Thrombosis News and Current Thrombosis Events RSSDES: New elements in the debate
Results announced at the 2006 ESC meeting in Barcelona questioned the long-term safety of drug eluting stents (DES) and sparked intense discussion.
Best use of drug-eluting stents
Compared with bare metal stents, drug-eluting stents substantially reduce the risk of angiographic and clinical recurrence but do not affect mortality or the short term or long term risk of myocardial infarction.
Tiny 3-D ultrasound probe guides catheter procedures
An ultrasound probe small enough to ride along at the tip of a catheter can provide physicians with clearer real-time images of soft tissue without the risks associated with conventional x-ray catheter guidance.
AJN study reveals compression stockings incorrectly used in 29 percent of patients
An original study, published in the September issue of the American Journal of Nursing (AJN), revealed that graduated compression stockings were used incorrectly in 29% of the patients and sized incorrectly in 26% of the patients.
New blood clot guidelines for pregnant women
New evidence-based guidelines address the prevention and management of thrombosis in key patient populations and reinforce recommendations related to the routine use of preventive therapies.
Computers as safe as medical experts for prescribing blood thinning drugs
The largest ever study into the administration of blood thinning drugs, principally Warfarin, has concluded that dosages calculated by computer are at least as safe and reliable as those provided by expert medical professionals.
Study shows pine bark naturally reduces cardiovascular risk factors in diabetics
A new study published in the May 2008 (volume 8, issue 25) edition of the journal of Nutrition Research shows Pycnogenol (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, reduces blood sugar in type II diabetes patients, allows people to lower their antihypertensive medication and improves cardiovascular disease (CVD) risk factors.
Quest for better treatment for effects of menopause
During menopause, lack of oestrogens increases the risk of suffering cardiovascular diseases. For her doctoral thesis, University of the Basque Country researcher, Ainhoa Ruiz del Agua, studied the effects of substitute treatments and the genetic factors influencing the response to these therapies.
Avoiding Spleen Removal for Cooley's Anemia Sufferers
Researchers from Weill Cornell Medical College may have discovered the precise role of a gene in one of the world's most common blood disorders, beta-thalassemia, commonly known as Cooley's anemia.
Study finds it pays to be heart smart if considering hormone therapy
A research study has found that a simple blood test may indicate whether post-menopausal hormone therapies present an elevated risk of a heart attack.
More Thrombosis News Articles
 | Disorders of Hemostasis & Thrombosis: A Clinical Guide by Scott H. Goodnight, William E. Hathaway Now expanded with new coverage of genetics, more therapy and management strategies, and more references throughout, this guide remains one of the most practical resources for diagnosis and treatment of hematologic conditions commonly seen in general practice. The clear, succinct language is meant for the non-hematologist who wants the salient points of clinical signs, etiology and... |
 | Consultative Hemostasis and Thrombosis by Craig S. Kitchens, Barbara M. Alving, Craig M. Kessler Effectively and efficiently diagnose and manage today's full range of clotting and bleeding disorders using clinical case studies that demonstrate real-world problems and solutions! For each condition examined, you'll review concise descriptions of its associated symptoms, along with laboratory findings, diagnosis, differential diagnosis, and treatment - all the clinical guidance you need - at... |
 | 100 Q&A About Deep Vein Thrombosis and Pulmonary Embolism (100 Questions & Answers about . . .) (100 Questions & Answers) by Andra H. James Nearly two million Americans are affected annually by deep vein thrombosis. Whether you're a newly diagnosed patient, or a loved one of someone suffering from this disease, this book offers help. The only text available to provide both the doctor's and patient's views, 100 Questions & Answers About Deep Vein Thrombosis and Pulmonary Embolism gives you authoritative, practical answers to your... |
 | Thrombus and Stroke (Neurological Disease and Therapy) Providing a clear foundation as to what a clot is, how it forms, and the most recent approaches to treatment this all inclusive resource on thrombus and stroke covers: · current pharmacological interventions · clinical management of stroke. · the fundamental science of clot formation and the pharmacokinetics of thrombolysis · latest findings on neurovascular... |
 | Thrombosis in Clinical Practice Designed for everyday use, primarily in the hospital setting, Thrombosis in Clinical Practice is a practical clinical reference to the management of thrombosis. The text provides a concise guide to the latest drugs and their applications and reviews appropriate therapeutic strategies for each of the most commonly-encountered clinical scenarios. Numerous flowcharts and checklists support and... |
 | Laboratory Techniques in Thrombosis - A Manual - 2nd Revised Edition of ECAT Assay Procedures The first edition of this manual appeared in 1992 and was entitled ECAT Assay Procedures. This completely revised new edition combines the strengths of the first edition with new and useful features. Laboratory Techniques in Thrombosis - a Manual still gives detailed descriptions of the recommended assays and their alternatives. However, the manual now has a broader scope because it is no... |
 | Practical Hemostasis and Thrombosis Provides a comprehensive yet concise and practical guide to the full range of clotting and bleeding disorders encountered in clinical practice.Presented in three sections, this book informs and advises clinicians in all stages of diagnosis, management and prevention of thrombotic and hemostatic disorders.Why Buy This Book?Essential practical management for all those working in the field of... |
 | Hemostasis and Thrombosis: Basic Principles and Clinical Practice (HEMOSTASIS AND THROMBOSIS) The pre-eminent reference on coagulation disorders is now in its thoroughly updated Fifth Edition. Written by more than 160 of the world's foremost authorities, this encyclopedic volume integrates basic science and clinical practice and details all that is currently known about blood clotting disorders and how to manage patients with these and related problems. This edition has been reorganized... |
| Multiple venous thromboses in a young man with sarcoidosis: is there a relation between sarcoidosis and venous thrombosis?(Case Report): An article from: Southern Medical Journal by Bobbak Vahid, Bernadette Wildemore, Paul E. Marik This digital document is an article from Southern Medical Journal, published by Thomson Gale on September 1, 2006. The length of the article is 1018 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle:... | |
 | Fibrinolytic and Antithrombotic Therapy: Theory, Practice, and Management by Richard C. Becker, Frederick A. Spencer Thrombotic disorders of the circulatory system represent the leading cause of morbidity, motality, and health care expenditure in the United States. Fibrinolytic and Antithrombotic Therapy provides a practical, evidence-based approach to the management of thrombotic disorders for all clinicians involved in the care of patients with these disorders. It provides not only vital conceptual... |
| © 2008 BrightSurf.com |